Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin.
This case report is only the third report of thyroid dysfunction following the administration of anti-lymphocyte globulin for severe aplastic anaemia. It is the first report of the development of Grave's disease. We discuss a possible mechanism by which this may occur and highlight instances of other immune-mediated diseases occurring in ALG treated patients.
Todd
A
A
Department of Haematology, Addenbrookes Hospital NHS Trust, Cambridge, UK.
Todd
J
J
D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D006111:Graves Disease / Q000139:chemically induced*; D006801:Humans; D008297:Male
D000961:Antilymphocyte Serum